Company · CIK 0001839970 · SIC 2834 — Pharmaceutical Preparations
BlossomHill Therapeutics, Inc. · BLSM
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 10, 2026 PForm 4 → | Aug 12, 4:46 pm EDT | Carl L GordonDirector | 625,000 | $16.00 | $10,000,000 | 2,714,279 | +29.9% | |
| Aug 10, 2026 CForm 4 → | Aug 12, 4:46 pm EDT | Carl L GordonDirector | 2,089,279 | — | — | 2,089,279 | — | |
| Aug 10, 2026 PForm 4 → | Aug 12, 4:43 pm EDT | ORBIMED ADVISORS LLC +1Director | 625,000 | $16.00 | $10,000,000 | 2,714,279 | +29.9% | |
| Aug 10, 2026 CForm 4 → | Aug 12, 4:43 pm EDT | ORBIMED ADVISORS LLC +1Director | 2,089,279 | — | — | 2,089,279 | — | |
| Aug 10, 2026 PForm 4 → | Aug 10, 6:35 pm EDT | John P. SchmidDirector | 6,000 | $16.00 | $96,000 | 6,000 | — | |
| Aug 10, 2026 PForm 4 → | Aug 10, 6:32 pm EDT | Bihua Chen +5Director, 10% Owner | 312,500 | $16.00 | $5,000,000 | 3,614,034 | +9.47% | |
| Aug 10, 2026 CForm 4 → | Aug 10, 6:32 pm EDT | Bihua Chen +5Director, 10% Owner | 3,301,534 | — | — | 3,301,534 | — | |
| Aug 10, 2026 CForm 4 → | Aug 10, 6:29 pm EDT | Sundeep AgrawalDirector | 578,524 | — | — | 578,524 | — | |
| Aug 10, 2026 PForm 4 → | Aug 10, 6:27 pm EDT | Jason A KeyesChief Financial Officer | 700 | $16.00 | $11,200 | 700 | — | |
| Aug 10, 2026 CForm 4 → | Aug 10, 6:26 pm EDT | Vincent Paul LiptakGeneral Counsel | 22,687 | — | — | 22,687 | — | |
| Aug 10, 2026 CForm 4 → | Aug 10, 6:23 pm EDT | Yishan LiExecutive Chairman, Director, 10% Owner | 1,838,896 | — | — | 124,779 | — | |
| Aug 10, 2026 CForm 4 → | Aug 10, 6:22 pm EDT | Jingrong Jean CuiPresident and CEO, Director, 10% Owner | 1,838,896 | — | — | 124,779 | — | |
| Aug 7, 2026 PForm 4 → | Aug 10, 6:26 pm EDT | Vincent Paul LiptakGeneral Counsel | 4,700 | $15.89 | $74,700 | 111,412 | +4.40% |
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 10, 2026 CForm 4 → | Aug 12, 4:46 pm EDT | Carl L GordonDirector | 2,089,279 | — | — | 0 | — | |
| Aug 10, 2026 CForm 4 → | Aug 12, 4:43 pm EDT | ORBIMED ADVISORS LLC +1Director | 2,089,279 | — | — | 0 | — | |
| Aug 6, 2026 AForm 4 → | Aug 10, 6:33 pm EDT | Carl L GordonDirector | 23,904 | — | — | 23,904 | — | |
| Aug 6, 2026 ACForm 4 → | Aug 10, 6:32 pm EDT | Bihua Chen +5Director, 10% Owner | 3,325,438 | — | — | 0 | — | |
| Aug 6, 2026 ACForm 4 → | Aug 10, 6:29 pm EDT | Sundeep AgrawalDirector | 602,428 | — | — | 0 | — | |
| Aug 6, 2026 AForm 4 → | Aug 10, 6:27 pm EDT | Jason A KeyesChief Financial Officer | 56,746 | — | — | 56,746 | — | |
| Aug 6, 2026 ACForm 4 → | Aug 10, 6:26 pm EDT | Vincent Paul LiptakGeneral Counsel | 69,248 | — | — | 0 | — | |
| Aug 6, 2026 AForm 4 → | Aug 10, 6:24 pm EDT | Geoffrey Raymond OxnardChief Medical Officer | 61,783 | — | — | 61,783 | — | |
| Aug 6, 2026 ACForm 4 → | Aug 10, 6:23 pm EDT | Yishan LiExecutive Chairman, Director, 10% Owner | 1,951,597 | — | — | 0 | — | |
| Aug 6, 2026 ACForm 4 → | Aug 10, 6:22 pm EDT | Jingrong Jean CuiPresident and CEO, Director, 10% Owner | 2,515,101 | — | — | 0 | — |